A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...

The company is conducting five registrational QWINT studies to establish that once-weekly efsitora is not inferior to daily insulin injection ... glargine and insulin degludec, respectively.

In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin degludec after completing the usual-care control group of a randomized trial. About Mary Ann Liebert, Inc., a Sage ...

For many patients with type 2 diabetes, having to inject basal insulin every day ... as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose ...

Tresiba (insulin degludec) may not be safe to use while pregnant or breastfeeding. Factors including the form you take or the condition being treated may determine whether you should use the drug ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...

After decades of optimizations to develop longer-acting insulin preparations to reduce the number of daily injections ... including long-acting insulin degludec, rapid-acting insulin aspart ...

This leaflet answers some common questions about Ryzodeg ® 70/30 FlexTouch ®. It does not contain all the available information. It does not take the place of talking to your doctor, diabetes ...